K-11017

N/A

Report date: 2023/02/04 20:01:27

Base Information

Drug NameK-11017

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeptide hydrolase inhibitors

TargetsPeptide hydrolase

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelera Genomics

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelera Genomics

Active IndicationsN/A

Inactive IndicationsGlioma

ATC CodeN/A